2Nanshan Zhong,Chen Wang,Wanzhen Yao,et at Prevalence of Chronic Obstructive Pulmonary Disease in China[J].AmJ Respir Cris Care Med,2007,176:753-760. 被引量：1
4Koum is T,Sam uel S,Tiotrop ium brom ide:a newlong-acting bronchodilator for for the treatment of the chronic obstructive pulmonary disease[J].Chli Ther,2005,27:377-392. 被引量：1
5GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989. 被引量：1
6Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946. 被引量：1
7Celli BR,Cote CG,Marin JM,ct al.The body mass index,airflow obstruction,dyspnea and exercise capacity index in chronic obstructive pulmonary disease.N Engl J Med,2004,350:1005-1012. 被引量：1
2RabeKF, Hurd S, AnzuetoA,et al. Global strategy for the di agnosis,management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary[J]. Am J Re- spir Crit Care Med,2007,176(6):532 551. 被引量：1
3Chakrabarti B, Calverley P, Davies PD. Tuberculosis and its incidence, special nature, and relationship with chronic ob structive pulmonary disease[J]. InterCOPD, 2007,2 (3) 263 721. 被引量：1
4Wang JY,Lee LN,Hsueh PR. Factors changing the manifes tation of pu-lmonary tuberculosis[J]. Int JTuberc LungDis, 2005,9(7) 777 831. 被引量：1
5Sandelowsky H, Stfillberg B, Nager A, et al. The prevalerme ofundiagnosed chronic obstructive pulmonary disease in a pri- marycare population with respiratory tract infections-a case finding study[J]. BMC Faro Pract, 2011,12 : 122. 被引量：1
6Shu CC, WuHD, YuMC, et al costeroids is associated with Use of high-dose inhaled corti pulmonary tuberculosis in pa tients with chronic obstructive pulmonary disease[J]. Medi cine(Baltimore), 2010,89(1) : 53 61. 被引量：1
7Bahadori K,FitzGerald JM, Levy RD,et al. Risk factors and outcomes associated with chronic obstructive pulmonary dis ease exacerbations requiring hospitalization[J]. Can Respir J, 2009,16(4) : e43-e49. 被引量：1
8Racil H, Ben Salem N, Chaouch N. Silicoproteinosis: a specific clinical and radiological entity. Rev Mal Respir, 2012, 29 (9) :1132-1136. 被引量：1
10Jarenback L1, Ankerst J, Bjermer L, et al .Flow-Volume Parameters in COPD Related to Extended Measurements of Lung Volume, Diffusion, and Resistance. Pulm Med, 2013: 782052. 被引量：1
